Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Vaxil Bio Ltd (V: VXL)

 
VXL Technical Analysis
5
As on 8th Jun 2023 VXL STOCK Price closed @ 0.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.04 & Strong Sell for SHORT-TERM with Stoploss of 0.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VXLSTOCK Price

Open 0.02 Change Price %
High 0.02 1 Day 0.00 0.00
Low 0.02 1 Week 0.00 0.00
Close 0.02 1 Month 0.00 0.00
Volume 67000 1 Year -0.07 -77.78
52 Week High 0.10 | 52 Week Low 0.02
 
V Canada Most Active Stocks
SNV 0.06 100.00%
GDNP 0.14 -17.65%
NOCR 0.02 0.00%
RHC 0.34 0.00%
NHHH 0.10 0.00%
VXTR 0.17 -5.56%
PGM 0.02 0.00%
FOM 3.23 3.86%
NBY 0.08 0.00%
GXU 0.15 0.00%
 
V Canada Top Gainers Stocks
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
 
V Canada Top Losers Stocks
VEC 43.92 -99.71%
VEC 43.92 -99.71%
VEC 43.92 -99.71%
VEC 43.92 -99.71%
TZR 0.05 -75.00%
SGMA 4.18 -63.65%
SGMA 4.18 -63.65%
VKG-H 0.02 -50.00%
MAP 0.01 -50.00%
MAP 0.01 -50.00%
 
 
VXL
Daily Charts		 VXL
Intraday Charts		 Whats New @
Bazaartrend		 VXL
Free Analysis
 
VXL Important Levels Intraday
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
 
VXL Forecast April 2024
Share
4th UP Forecast0.1
3rd UP Forecast0.07
2nd UP Forecast0.06
1st UP Forecast0.04
1st DOWN Forecast0
2nd DOWN Forecast-0.02
3rd DOWN Forecast-0.03
4th DOWN Forecast-0.06
 
VXL Weekly Forecast
4th UP Forecast0.04
3rd UP Forecast0.03
2nd UP Forecast0.03
1st UP Forecast0.03
1st DOWN Forecast0.01
2nd DOWN Forecast0.01
3rd DOWN Forecast0.01
4th DOWN Forecast0.00
 
VXL Forecast2024
4th UP Forecast0.19
3rd UP Forecast0.14
2nd UP Forecast0.1
1st UP Forecast0.07
1st DOWN Forecast-0.03
2nd DOWN Forecast-0.06
3rd DOWN Forecast-0.1
4th DOWN Forecast-0.15
 
 
VXL Other Details
Segment EQ
Market Capital 11613464.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VXL Address
VXL
 
VXL Latest News
 
Your Comments and Response on Vaxil Bio Ltd
 
VXL Business Profile
Vaxil Bio Ltd., an immunotherapy biotech company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company's lead product is ImMucin that has completed a Phase I/II clinical trial for the treatment of multiple myeloma. It is also developing a tuberculosis vaccine/treatment and a coronavirus (COVID-19) vaccine. The company has a collaboration agreement with The Tel Aviv Sourasky Medical Center for the company's research program to develop a potential peptide vaccine against COVID-19; and cooperative research and development agreement with U.S. Army Medical Research Institute of Infectious Diseases for testing CorVax for its ability to prevent COVID-19 in mice. The company was founded in 2006 and is headquartered in Toronto, Canada. Address: 3400 One First Canadian Place, Toronto, ON, Canada, M5X 1A4
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service